Mechanisms underlying clinical efficacy of Angiotensin II type 2 receptor (AT(2)R) antagonist EMA401 in neuropathic pain: clinical tissue and in vitro studies

BACKGROUND: The clinical efficacy of the Angiotensin II (AngII) receptor AT(2)R antagonist EMA401, a novel peripherally-restricted analgesic, was reported recently in post-herpetic neuralgia. While previous studies have shown that AT(2)R is expressed by nociceptors in human DRG (hDRG), and that EMA4...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Mol Pain
Auteurs principaux: Anand, Uma, Yiangou, Yiangos, Sinisi, Marco, Fox, Michael, MacQuillan, Anthony, Quick, Tom, Korchev, Yuri E, Bountra, Chas, McCarthy, Tom, Anand, Praveen
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2015
Sujets:
Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4482278/
https://ncbi.nlm.nih.gov/pubmed/26111701
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12990-015-0038-x
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires